Brief: Acorda Therapeutics Reports First Quarter 2022 Financial Results

Acorda Therapeutics

11/05/2022 21:36

May 11 (Reuters) - Acorda Therapeutics Inc  ACOR.O :
    * ACORDA THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
    * ACORDA THERAPEUTICS INC - GAAP NET LOSS OF $25.6 MILLION
FOR
QUARTER ENDED MARCH 31, 2022, OR $1.93 PER DILUTED SHARE
    * ACORDA THERAPEUTICS INC - NON-GAAP NET LOSS FOR QUARTER
ENDED
MARCH 31, 2022 WAS $22.0 MILLION, OR $1.66 PER DILUTED SHARE
    * ACORDA THERAPEUTICS INC - AT MARCH 31, 2022, COMPANY HAD
CASH,
CASH EQUIVALENTS, AND RESTRICTED CASH OF $51.5 MILLION
    * ACORDA THERAPEUTICS INC - FOR FULL YEAR 2022, ACORDA
CONTINUES
TO EXPECT AMPYRA NET REVENUE TO BE $68 - $78 MILLION

Source text for Eikon:  ID:nBw50sJZba 
Further company coverage:  ACOR.O 

 ((Reuters.Briefs@thomsonreuters.com;))